<DOC>
	<DOCNO>NCT02966080</DOCNO>
	<brief_summary>Heparin blood thinner use prevent blood clot patient form life-support call ECMO . Heparin cause bleed - common complication ECMO . New material use ECMO machine may help prevent clot - could allow use low dos heparin might reduce risk bleeding . Our study compare low dose high dose heparin patient ECMO . We think low dose heparin may adequate prevent clotting , may cause less bleed safe patient .</brief_summary>
	<brief_title>Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion Adults Receiving Venovenous ECMO With Heparin Bonded Circuit .</brief_title>
	<detailed_description>Intravenous heparin consider standard therapy prevent clot complication patient ECMO , however optimal method heparin dose yet determine . International survey show ECMO center use adjust dose heparin achieve activate clotting time least 180 second . However , heparin may contribute common complication ECMO - bleeding . Advances material technology potentially reduce thrombogenicity modern ECMO circuit . Our observational data suggest fix low dose heparin infusion may reduce rate bleeding complication 75 % 50 % compare standard adjusted-dose heparin , without increase clot complication . We intend perform randomize controlled trial adult receive venovenous ECMO compare two heparin regimen . The main outcome measure bleed complication oxygenator failure due clotting . A safety committee monitor result study . Power calculation indicate sample size 110 patient require , estimate take u five year achieve .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>ECMO acute respiratory failure , achieve ECMO blood flow rate &gt; 3L/min , patient surrogate able speak/understand English Spanish History heparininduced thrombocytopenia , decision clinician run ECMO heparin due high bleeding risk , pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>extracorporeal membrane oxygenation</keyword>
	<keyword>intravenous heparin</keyword>
</DOC>